Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1963 1
1976 1
1978 2
1985 1
1986 2
1988 3
1989 2
1991 1
1992 1
1993 1
1994 3
1995 5
1996 11
1997 3
1998 11
1999 13
2000 12
2005 1
2006 2
2008 2
2010 1
2012 1
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 9481001

86 results
Results by year
Filters applied: . Clear all
Page 1
Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program.
Weibel RE, Caserta V, Benor DE, Evans G. Weibel RE, et al. Pediatrics. 1998 Mar;101(3 Pt 1):383-7. doi: 10.1542/peds.101.3.383. Pediatrics. 1998. PMID: 9481001
Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
Usonis V, Bakasenas V, Kaufhold A, Chitour K, Clemens R. Usonis V, et al. Pediatr Infect Dis J. 1999 Jan;18(1):42-8. doi: 10.1097/00006454-199901000-00011. Pediatr Infect Dis J. 1999. PMID: 9951979 Clinical Trial.
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC). Marin M, et al. MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530 Free article.
Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).
Kuter BJ, Brown ML, Hartzel J, Williams WR, EvesiKaren A, Black S, Shinefield H, Reisinger KS, Marchant CD, Sullivan BJ, Thear M, Klopfer S, Xu J, Gress JO, Schödel F; Study Group for ProQuad. Kuter BJ, et al. Hum Vaccin. 2006 Sep-Oct;2(5):205-14. doi: 10.4161/hv.2.5.3246. Hum Vaccin. 2006. PMID: 17035730
Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins.
Jonville-Béra AP, Autret E, Galy-Eyraud C, Hessel L. Jonville-Béra AP, et al. Pediatr Infect Dis J. 1996 Jan;15(1):44-8. doi: 10.1097/00006454-199601000-00010. Pediatr Infect Dis J. 1996. PMID: 8684875
Polio vaccine and polio.
Sepkowitz S. Sepkowitz S. Pediatrics. 1999 Mar;103(3):694-5; author reply 695-6. Pediatrics. 1999. PMID: 10189298 No abstract available.
Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
Weibel RE, Buynak EB, McLean AA, Hilleman MR. Weibel RE, et al. Pediatrics. 1978 Jan;61(1):5-11. Pediatrics. 1978. PMID: 263873
[Drug clinics. Drug of the month. A new measles-rubella-mumps vaccine (Priorix)].
Senterre J. Senterre J. Rev Med Liege. 1999 Feb;54(2):122-4. Rev Med Liege. 1999. PMID: 10221066 French.
Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association.
DeStefano F, Chen RT. DeStefano F, et al. J Pediatr. 2000 Jan;136(1):125-6. J Pediatr. 2000. PMID: 10681219 No abstract available.
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; VAERS team. Asatryan A, et al. Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255204 Review.
86 results
Jump to page
Feedback